Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catumaxomab with/without Prednisolone in Malignant Ascites
NCT00822809Phase 3Completed
- Sponsor
- Neovii Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Nov 2010
- Modality
- Bispecific Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of catumaxomab in malignant ascites, sponsored by Neovii Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
catumaxomab
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT00822809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822809.